| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |